Publisher
Springer International Publishing
Reference100 articles.
1. Arthritis Alliance of Canada. The impact of arthritis in Canada: today and over the next 30 years. 2011. http://www.arthritisnetwork.ca/downloads/20111022_Impact_of_arthritis.pdf . Accessed 20 Jul 2012.
2. El Miedany Y. Comorbidity index in rheumatoid arthritis. Time to think. Clin Rheumatol. 2015;34:1995–2000.
3. Palmer D, El Miedany Y. Shared decision making for patients living with inflammatory arthritis. Br J Nurs. 2016;25(1):2–6.
4. Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol. 1994;21 Suppl 41:86–9.
5. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36:729–40.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献